| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMICUS THERAPEUTICS INC | 4,250,199 | 59,460,000 | 15.46% | ||
| 2 | MIRATI THERAPEUTICS INC COM | 1,453,055 | 50,014,000 | 13.00% | ||
| 3 | VANDA PHARMACEUTICALS INC COM | 2,124,593 | 23,965,000 | 6.23% | ||
| 4 | NEURODERM LTD | 1,103,093 | 22,801,000 | 5.93% | ||
| 5 | LA JOLLA PHARMACEUTICAL CO | 804,299 | 22,351,000 | 5.81% | ||
| 6 | ACADIA PHARMACEUTICALS INC COM | 581,900 | 19,243,000 | 5.00% | ||
| 7 | PERNIX THERAPEUTICS HLDGS IN | 6,004,564 | 18,974,000 | 4.93% | ||
| 8 | Lion Biotechnologies | 3,180,913 | 18,322,000 | 4.76% | ||
| 9 | SORRENTO THERAPEUTICS INC COM NEW | 2,151,437 | 18,051,000 | 4.69% | ||
| 10 | ONCOTHYREON INC COM N/C EFF 6/ | 5,506,618 | 15,088,000 | 3.92% | ||
| 11 | SAREPTA THERAPEUTICS INC | 469,025 | 15,060,000 | 3.92% | ||
| 12 | IGI LABS INC | 1,779,782 | 11,640,000 | 3.03% | ||
| 13 | AEGERION PHARMACEUTICALS INC | 806,300 | 10,966,000 | 2.85% | ||
| 14 | AGENUS INC | 2,199,137 | 10,116,000 | 2.63% | ||
| 15 | DERMIRA INC | 363,250 | 8,478,000 | 2.20% | ||
| 16 | SPECTRUM PHARMACEUTICALS INC COM | 1,315,600 | 7,867,000 | 2.05% | ||
| 17 | Nantkwest Inc | 728,887 | 7,301,000 | 1.90% | ||
| 18 | Innocoll | 502,422 | 6,290,000 | 1.64% | ||
| 19 | Egalet Corp | 440,606 | 5,807,000 | 1.51% | ||
| 20 | AXOVANT SCIENCES LTD | 406,470 | 5,252,000 | 1.37% | ||
| 21 | ISHARES TR | 1,280,000 | 4,979,000 | 1.29% | Put | |
| 22 | VERACYTE INC | 772,297 | 3,622,000 | 0.94% | ||
| 23 | TRILLIUM THERAPEUTICS INC | 255,097 | 3,351,000 | 0.87% | ||
| 24 | FORTRESS BIOTECH INC | 1,275,521 | 3,316,000 | 0.86% | ||
| 25 | VERICEL CORP | 1,135,120 | 3,076,000 | 0.80% | ||
| 26 | ALLIQUA BIOMEDICAL INC | 850,000 | 2,695,000 | 0.70% | ||
| 27 | TONIX PHARMACEUTICALS HLD | 410,300 | 2,170,000 | 0.56% | ||
| 28 | Heat Biologics Inc Com | 341,064 | 1,576,000 | 0.41% | ||
| 29 | SAREPTA THERAPEUTICS INC | 178,300 | 1,237,000 | 0.32% | Call | |
| 30 | CELLECTIS S A | 35,000 | 923,000 | 0.24% | ||
| 31 | Catalyst Biosciences | 83,901 | 391,000 | 0.10% | ||
| 32 | HERON THERAPEUTICS INC | 500,000 | 153,000 | 0.04% | Call | |
| 33 | KITE PHARMA INCORPORATED | 26,000 | 113,000 | 0.03% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065143, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
